Oncology Imaging Software Market Size & Share; By Active (Thymosins, Interferons, Interleukins, Glucan, Lipopolysaccharides, Levamisole, Isoprinosine); Immunodeficiency Disorders (Chronic infections, Cancer, Organ Transplantation); Type (CT, MRI, MRA); Application (Clinical Routine, Clinical Trials); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5905
  • Published Date: Mar 20, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Oncology Imaging Software Market size is expected to reach USD 7 Billion by the end of 2036, growing at a CAGR of 6% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of oncology imaging software was USD 4 Billion. The increasing prevalence of cancer worldwide will propel the market of oncology imaging software by the end of 2036. For instance, in 2022, there were a calculated 20 million advanced cancer cases and 9.7 million passings. The analyzed number of individuals who were lively inside 5 a long time taking after a cancer persistence was 53.5 million. Roughly 1 in 5 individuals create cancer in their lifetime, around 1 in 9 men and 1 in 12 ladies kick the bucket from the infection. The global WHO study on UHC and cancer shows that as it were 39% of partaking nations secured the essentials of cancer administration as a part of their financed center well-being administrations for all citizens, 'health advantage packages' (HBP).

Another reason that will propel the market of oncology imaging software by the end of 2036 is the increasing demand for early diagnosis and customized therapy. As cancer cases are becoming prevalent, there remains a pressing need for early diagnosis to get treated efficiently. To illustrate the truth that, in Britain, over 90% of cancers are recognized exterior the three national screening programs (for cervical, breast, and bowel cancers) accentuate the importance of showcasing expeditiously imperative care with possible cancer indications. The importance of symptomatic introduction is emphasized by the developing eagerness for campaigns to progress open mindfulness of the early signs of cancer. Their discoveries furthermore have necessary suggestions for health-care specialists since provoking referral and examination of potential cancer indications post-presentation is another step in guaranteeing opportune determination. Inquire about appears that universal variety exists within the status to explore or allude to auxiliary care for suspected cancer indications, and nations where healthcare experts illustrate more prominent availability watch the most noteworthy cancer survival rates.


Oncology Imaging Software Market
Get more information on this report: Request Free Sample PDF

Oncology Imaging Software Sector: Growth Drivers and Challenges

Growth Drivers

  • Increasing Demand for Cloud-based Solutions - Picture chronicling and communication frameworks (PACS) play a crucial part in progressed radiology by providing a computerized stage for the potential, recovery, dissemination, and introduction of corrective pictures. A PACS acts as a computer to organize digitized radiological pictures and reports. Further patterns in PACS have transferred absent from standalone structures to enterprise imaging structures that interconnected not as it were radiology but all offices that generate imaging and image-associated reports so they can be concentrated in one area and interconnected into the overarching electronic restorative record (EMR). A few PACS patterns were demonstrated at RSNA23. Chief among them: is cloud-depended PACS. Multiple healthcare suppliers are shifting toward cloud-based PACS dispositions, allowing less requiring entrance to corrective pictures from various areas, promising cooperation among healthcare specialists, and decreasing the need for on-premises cornerstones.
  • Advancement in Technology of Oncology Imaging - A few instrumented progressions like check speed, dual-energy, reciprocating remaking, moo kilovolt, perfusion imaging, and radiation dosage reduction have stressed the clinical utility of CT-based tumor imaging. Correlative imaging has ended up as a basic apparatus in this zone. It comprises various techniques implemented to imagine the human body's insides for clinical assessment and corrective mediation. Inside the setting of oncology, therapeutic imaging acts as a multifaceted part. It assists in early location, when cancer may be most curable, by providing a non-invasive manner to think of tumors. Utilization of planning like X-rays, Computed Tomography (CT) filters, Attractive Reverberation Imaging (MRI), and Positron Outflow Tomography (PET) verifications are habitually implemented to recognize and find tumors, indeed in their beginning stages.
  • Increasing Occurrence of Artificial Intelligence (AI) and Machine Learning (ML) Technologies - The current growth in the area has taken to considerably increased the effectiveness of the technology, which can be utilized to industrialize the gatherings and documentation of date of diagnosis, advancement-free survival, and other cancer-associated tumor characteristics and patient results. Quick-growing imaging creation and explanatory apparatuses enable radiology to act a gradually essential part in cancer screening, resolution arranging, reaction appraisal, and guessing.

Challenges

  • High Disease Pressure of Cancer - Hypertension is more common in patients on anticancer treatment than in the general population as an outcome of numerous mechanisms, comprising direct vascular and renal impacts of anticancer treatment. Hypertension and blood pressure (BP) lability start at the time of commencement of anticancer treatment and remain lifelong, which can outcome in interruptions in therapy and place patients at enhanced risk of cardiovascular disease (CVD) and mortality. Cancer and CVD are major causes of gloominess and mortality internationally. Hypertension is one of the most opportunity agents for the modification of CVD, comprising ischemic heart illness, heart frustration, stroke, and kidney illness. The supremacy of hypertension across the world is extending, coming to 1.3 billion grown-ups in 2019 Despite the accessibility of compelling antihypertensive drugs, BP is insufficiently controlled in nearly 50% of those known to have hypertension.
  • Stringent Government Policies
  • Lack of Knowledge in People about Cancer

Oncology Imaging Software Market: Key Insights

Base Year

2023

Forecast Year

2036

CAGR

∼6%

Base Year Market Size (2023)

~USD 4 Billion

Forecast Year Market Size (2036)

~USD 7 Billion

Regional Scope

  • North America (North America, Canada, Mexico)
  • Asia Pacific (Japan, China, India, Australia, Others)
  • Europe (Germany, Spain, UK, France, Italy, Russia, Others)
  • Middle East and Africa (South Africa, UAE, Others)
  • Latin America (Brazil, Argentina, Others)
Get more information on this report: Request Free Sample PDF

Oncology Imaging Software Segmentation

Type (CT, MRI, MRA)

The MRA segment will grow the most by the forecast period and will hold almost 58% of the oncology imaging software market because of its extensive use in diagnosing cancer worldwide. An MRA employments a solid attractive field and radio waves to make pictures. The supplier can notice these pictures on a computer. Not at all such as an X-ray, an MRA doesn't implement radiation. It gets information from your body's vitality in an attractive field. A few imaging tests, such as ultrasounds and magnetic reverberation imaging (MRI), don't utilize radiation. In case a person has a test that employs radiation, such as X-rays and computed tomography (CT), then the specialists utilize the least measurements of radiation conceivable to still provide us with very high-quality pictures. Specialists utilize imaging tests to assist in discovering and diagnosing disease, suggest medications, and screen how well it reacts to treatment Thus, this segment will grow massively in the oncology imaging software market.

Immunodeficiency Disorders (Chronic infections, Cancer, Organ Transplantation)

The cancer segment will have superior growth during the forecast period and will hold around 40% of the revenue share of the oncology imaging software market owing to the increasing prevalence of cancer cases and cancer biomarkers worldwide. There were an evaluated 18.1 million cancer cases around the world in 2020. Of these, 9.3 million cases were in men and 8.8 million in ladies. With this developing global burden, dodging cancer is one of the chief remarkable open well-being challenges of the 21st century. Our Cancer Avoidance Suggestions pull together as a usual manner of living powerfully to evade cancer through transforming dietary designs, reducing liquor implementation, broadening physical action, and achieving and sustaining sound body weight. Thus, the cancer segment will grow immensely in the oncology imaging software market.

Our in-depth analysis of the global market includes the following segments:

          Active

  • Thymosins
  • Interferons
  • Interleukins
  • Glucan
  • Lipopolysaccharides
  • Levamisole
  • Isoprinosine

          Immunodeficiency Disorders

  • Chronic infections
  • Cancer
  • Organ Transplantation

          Type

  • CT
  • MRI
  • MRA

          Application

  • Clinical Routine
  • Clinical Trials

          Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Oncology Imaging Software Industry - Regional Synopsis

North American Market Statistics

The oncology imaging software market in the North America region will have the biggest growth during the forecast period with a revenue share of around 41%. This growth will be noticed owing to the increasing demand for oncology imaging software in this region. Progresses in two-dimensional parallel imaging enhancement, compressed sensing undersampling, and concurrent multislice acquirement recently enabled clinically accessible fourfold to eightfold enhancement of musculoskeletal MRI on 1.5-T and 3.0-T scanners. Thus, the oncology imaging software market in the North American region will have the biggest share of market revenue.

European Market Analysis

The oncology imaging software market in the Europe region will also encounter huge growth during the forecast period and will hold the second position owing to the rising investment in medicated imaging tools by the big key players. For instance, in July 2022, Siemens Healthineers launched its latest mobile X-ray system, Mobilett Impact. The latest system is pocket-friendly and accompanies full digital unification, combining the advantages of mobile X-ray imaging at a patient’s bedside. Multiple groundbreaking technologies have also been denoted by top contenders in the medical imaging business domain to match the increasing requirement for X-ray imaging results for efficient medical diagnosis. Thus, in the European region, the market for oncology imaging software will expand massively.

Research Nester
Oncology Imaging Software Market size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Oncology Imaging Software Landscape

top-features-companies
    • Pfizer Inc.
    • Company Overview
    • Business Planning
    • Main Product Offerings
    • Financial Execution
    • Main Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
    • Step-Pharma
    • Novartis A.G.
    • Abbott
    • Amgen Inc.
    • Biogen
    • Johnson & Johnson
    • Merck & Co.
    • Eli Lilly and Company
    • Hoffmann-La Roche Ltd.

In-the-news

In The News

  • Pfizer Inc. drafted its strategic priorities for the freshly formed Oncology organization-and how its intense and various pipeline, industry-leading Oncology expertise and projected near- and mid-term catalysts are projected to position the organization to provide powerful expansion and shareholder value. A playback of the webcast and associated components, comprising the presentations and a summary and transcript, will be made accessible on Pfizer investor relations.
  • Pfizer Inc. declared top-line ABRYSVO® vaccine effectiveness and protection data for the respiratory syncytial virus (RSV) in adults 60 years of age and older following a second season in the Northern and Southern Hemispheres from the continuous pivotal Phase 3 clinical trial RENOIR (RSV vaccine Efficacy study iNOlder adults Immunized against RSV disease).

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5905
  • Published Date: Mar 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The increasing prevalence of cancer worldwide will majorly drive the market growth of the oncology imaging software market.

The market size of the oncology imaging software market is expected to get a CAGR of approximately 6% over the forecast period, i.e., 2024-2036.

The major players in the market are Pfizer Inc., Step-Pharma, Novartis A.G., Abbott, Amgen Inc., Biogen, Johnson & Johnson, Merck & Co., Eli Lilly and Company, Hoffmann-La Roche Ltd., Sysmex Corporation, Olympus Corporation, Omron Corporation, Shimadzu Corporation.

The MRA segment is anticipated to reap the largest market size with almost 58% by the end of 2036 and demonstrate substantial growth scopes.

The market in the North American region is expected to have the largest market share by the end of 2036 and provide more business opportunities in the future.
Oncology Imaging Software Market Report Scope
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying